Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
A series of phase I clinical studies were conducted to evaluate the safety of plasmid DNA and modified vaccinia virus Ankara malaria vaccines. The vaccines each encoded a polyepitope string fused to whole Plasmodium falciparum TRAP antigen. Forty-three healthy adult volunteers received the vaccines...
मुख्य लेखकों: | Moorthy, V, McConkey, S, Roberts, M, Gothard, P, Arulanantham, N, Degano, P, Schneider, J, Hannan, C, Roy, M, Gilbert, S, Peto, T, Hill, A |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2003
|
समान संसाधन
-
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
द्वारा: Moorthy, V, और अन्य
प्रकाशित: (2003) -
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
द्वारा: Webster, D, और अन्य
प्रकाशित: (2006) -
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
द्वारा: McConkey, S, और अन्य
प्रकाशित: (2003) -
Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
द्वारा: Dégano, P, और अन्य
प्रकाशित: (1999) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
द्वारा: Moorthy, V, और अन्य
प्रकाशित: (2003)